Ajooni Biotech (India) Performance
| AJOONI Stock | 7.42 0.04 0.54% |
The firm shows a Beta (market volatility) of -0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Ajooni Biotech are expected to decrease at a much lower rate. During the bear market, Ajooni Biotech is likely to outperform the market. Ajooni Biotech right now shows a risk of 3.15%. Please confirm Ajooni Biotech semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if Ajooni Biotech will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ajooni Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ajooni Biotech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Last Split Factor 5:1 | Last Split Date 2022-10-07 |
1 | Multibagger Penny Stock Under 10 Jumps After Reporting Strong Q2FY25 Result With Growth Of 52 Per Cent In PAT On Yearly Basis - Dalal Street Investment Journal | 11/19/2024 |
| Begin Period Cash Flow | 3.1 M |
Ajooni |
Ajooni Biotech Relative Risk vs. Return Landscape
If you would invest 765.00 in Ajooni Biotech Limited on August 24, 2024 and sell it today you would lose (23.00) from holding Ajooni Biotech Limited or give up 3.01% of portfolio value over 90 days. Ajooni Biotech Limited is generating 1.0E-4% of daily returns and assumes 3.1466% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Ajooni, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ajooni Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ajooni Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ajooni Biotech Limited, and traders can use it to determine the average amount a Ajooni Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AJOONI |
Estimated Market Risk
| 3.15 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ajooni Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ajooni Biotech by adding Ajooni Biotech to a well-diversified portfolio.
Ajooni Biotech Fundamentals Growth
Ajooni Stock prices reflect investors' perceptions of the future prospects and financial health of Ajooni Biotech, and Ajooni Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ajooni Stock performance.
| Return On Equity | 0.0354 | ||||
| Return On Asset | 0.0139 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 754.71 M | ||||
| Shares Outstanding | 99.37 M | ||||
| Price To Book | 1.73 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 800.01 M | ||||
| Gross Profit | 87.45 M | ||||
| EBITDA | 44.27 M | ||||
| Net Income | 21.61 M | ||||
| Total Debt | 21.68 M | ||||
| Book Value Per Share | 4.88 X | ||||
| Cash Flow From Operations | (39.52 M) | ||||
| Earnings Per Share | 0.22 X | ||||
| Total Asset | 475.2 M | ||||
| Retained Earnings | 86.91 M | ||||
About Ajooni Biotech Performance
By analyzing Ajooni Biotech's fundamental ratios, stakeholders can gain valuable insights into Ajooni Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ajooni Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ajooni Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ajooni Biotech is entity of India. It is traded as Stock on NSE exchange.Things to note about Ajooni Biotech performance evaluation
Checking the ongoing alerts about Ajooni Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ajooni Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ajooni Biotech had very high historical volatility over the last 90 days | |
| Ajooni Biotech generates negative cash flow from operations | |
| Latest headline from news.google.com: Multibagger Penny Stock Under 10 Jumps After Reporting Strong Q2FY25 Result With Growth Of 52 Per Cent In PAT On Yearly Basis - Dalal Street Investment Journal |
- Analyzing Ajooni Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ajooni Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Ajooni Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ajooni Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ajooni Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ajooni Biotech's stock. These opinions can provide insight into Ajooni Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ajooni Stock analysis
When running Ajooni Biotech's price analysis, check to measure Ajooni Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajooni Biotech is operating at the current time. Most of Ajooni Biotech's value examination focuses on studying past and present price action to predict the probability of Ajooni Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajooni Biotech's price. Additionally, you may evaluate how the addition of Ajooni Biotech to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |